361 related articles for article (PubMed ID: 17118749)
1. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix.
Behnam K; Murray SS; Brochmann EJ
Connect Tissue Res; 2006; 47(5):271-7. PubMed ID: 17118749
[TBL] [Abstract][Full Text] [Related]
2. The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2.
Lin H; Zhao Y; Sun W; Chen B; Zhang J; Zhao W; Xiao Z; Dai J
Biomaterials; 2008 Mar; 29(9):1189-97. PubMed ID: 18083224
[TBL] [Abstract][Full Text] [Related]
3. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
Gutierrez J; Osses N; Brandan E
J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756
[TBL] [Abstract][Full Text] [Related]
4. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
[TBL] [Abstract][Full Text] [Related]
5. Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide.
Chen B; Lin H; Zhao Y; Wang B; Zhao Y; Liu Y; Liu Z; Dai J
J Biomed Mater Res A; 2007 Feb; 80(2):428-34. PubMed ID: 17013862
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and sensitive in vitro assay for osteoinductive activity of demineralized bone matrix.
Han B; Tang B; Nimni ME
J Orthop Res; 2003 Jul; 21(4):648-54. PubMed ID: 12798064
[TBL] [Abstract][Full Text] [Related]
7. Cartilage-derived morphogenetic proteins enhance the osteogenic protein-1-induced osteoblastic cell differentiation of C2C12 cells.
Yeh LC; Tsai AD; Zavala MC; Lee JC
J Cell Physiol; 2004 Dec; 201(3):401-8. PubMed ID: 15389555
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes.
Rosen V; Nove J; Song JJ; Thies RS; Cox K; Wozney JM
J Bone Miner Res; 1994 Nov; 9(11):1759-68. PubMed ID: 7532346
[TBL] [Abstract][Full Text] [Related]
10. Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products.
Bae HW; Zhao L; Kanim LE; Wong P; Delamarter RB; Dawson EG
Spine (Phila Pa 1976); 2006 May; 31(12):1299-306; discussion 1307-8. PubMed ID: 16721289
[TBL] [Abstract][Full Text] [Related]
11. Deletion mutants of BMP folding variants act as BMP antagonists and are efficient inhibitors for heterotopic ossification.
Weber FE; Schmökel H; Oelgeschläger M; Nickel J; Maly FE; Hortschansky P; Grätz KW
J Bone Miner Res; 2003 Dec; 18(12):2142-51. PubMed ID: 14672349
[TBL] [Abstract][Full Text] [Related]
12. Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo.
Zhou H; Qian J; Wang J; Yao W; Liu C; Chen J; Cao X
Biomaterials; 2009 Mar; 30(9):1715-24. PubMed ID: 19131102
[TBL] [Abstract][Full Text] [Related]
13. Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats.
Takita H; Vehof JW; Jansen JA; Yamamoto M; Tabata Y; Tamura M; Kuboki Y
J Biomed Mater Res A; 2004 Oct; 71(1):181-9. PubMed ID: 15368268
[TBL] [Abstract][Full Text] [Related]
14. Effects of growth factors on cell migration and alkaline phosphatase release.
Gonnerman KN; Brown LS; Chu TM
Biomed Sci Instrum; 2006; 42():60-5. PubMed ID: 16817586
[TBL] [Abstract][Full Text] [Related]
15. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
[TBL] [Abstract][Full Text] [Related]
16. Osteoinductivity of partially purified bovine, ostrich and emu bone morphogenetic proteins in vitro.
Hu Z; Peel SA; Lindholm TC; Sàndor GK; Clokie CM; Su Y
J Biomed Mater Res A; 2011 Sep; 98(3):473-7. PubMed ID: 21630431
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
18. Multidomain synthetic peptide B2A2 synergistically enhances BMP-2 in vitro.
Lin X; Zamora PO; Albright S; Glass JD; Peña LA
J Bone Miner Res; 2005 Apr; 20(4):693-703. PubMed ID: 15765189
[TBL] [Abstract][Full Text] [Related]
19. Uptake of nickel from 316L stainless steel into contacting osteoblastic cells and metal ion interference with BMP-2-induced alkaline phosphatase.
Mölders M; Felix J; Bingmann D; Hirner A; Wiemann M
J Biomed Mater Res A; 2007 Nov; 83(2):303-12. PubMed ID: 17437303
[TBL] [Abstract][Full Text] [Related]
20. Assay of bone morphogenetic protein-2, -4, and -7 in human demineralized bone matrix.
Pietrzak WS; Woodell-May J; McDonald N
J Craniofac Surg; 2006 Jan; 17(1):84-90. PubMed ID: 16432413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
